Literature DB >> 28983453

Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.

Zidong Donna Fu1, Julia Yue Cui1.   

Abstract

Recent technological advancements including metagenomics sequencing and metabolomics have allowed the discovery of critical functions of gut microbiota in obesity, malnutrition, neurological disorders, asthma, and xenobiotic metabolism. Classification of the human gut microbiome into distinct "enterotypes" has been proposed to serve as a new paradigm for understanding the interplay between microbial variation and human disease phenotypes, as many organs are affected by gut microbiota modifications during the pathogenesis of diseases. Gut microbiota remotely interacts with liver and other metabolic organs of the host through various microbial metabolites that are absorbed into the systemic circulation. PURPOSE OF REVIEW: The present review summarizes recent literature regarding the importance of gut microbiota in modulating the physiological and pathological responses of various host organs, and describes the functions of the known microbial metabolites that are involved in this remote sensing process, with a primary focus on the gut microbiota-liver axis. RECENT
FINDINGS: Under physiological conditions, gut microbiota modulates the hepatic transcriptome, proteome, and metabolome, most notably down-regulating cytochrome P450 3a mediated xenobiotic metabolism. Gut microbiome also modulates the rhythmicity in liver gene expression, likely through microbial metabolites, such as butyrate and propionate that serve as epigenetic modifiers. Additionally, the production of host hormones such as primary bile acids and glucagon like peptide 1 is altered by gut microbiota to modify intermediary metabolism of the host.
SUMMARY: Dysregulation of gut microbiota is implicated in various liver diseases such as alcoholic liver disease, non-alcoholic steatohepatitis, liver cirrhosis, cholangitis, and liver cancer. Gut microbiota modifiers such as probiotics and prebiotics are increasingly recognized as novel therapeutic modalities for liver and other types of human diseases.

Entities:  

Keywords:  Bile acids; Choline metabolites; Intestine microbiome; Liver diseases; Microbial metabolites; Short-chain fatty acids

Year:  2017        PMID: 28983453      PMCID: PMC5624329          DOI: 10.1007/s40495-017-0087-0

Source DB:  PubMed          Journal:  Curr Pharmacol Rep        ISSN: 2198-641X


  130 in total

Review 1.  The interaction between bacteria and bile.

Authors:  Máire Begley; Cormac G M Gahan; Colin Hill
Journal:  FEMS Microbiol Rev       Date:  2005-09       Impact factor: 16.408

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

Review 3.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

4.  Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption.

Authors:  Guoxiang Xie; Wei Zhong; Houkai Li; Qiong Li; Yunping Qiu; Xiaojiao Zheng; Huiyuan Chen; Xueqing Zhao; Shucha Zhang; Zhanxiang Zhou; Steven H Zeisel; Wei Jia
Journal:  FASEB J       Date:  2013-05-24       Impact factor: 5.191

5.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

Review 6.  Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Authors:  Sena Bluemel; Brandon Williams; Rob Knight; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-29       Impact factor: 4.052

7.  The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.

Authors:  Martin Kummen; Kristian Holm; Jarl Andreas Anmarkrud; Ståle Nygård; Mette Vesterhus; Marte L Høivik; Marius Trøseid; Hanns-Ulrich Marschall; Erik Schrumpf; Bjørn Moum; Helge Røsjø; Pål Aukrust; Tom H Karlsen; Johannes R Hov
Journal:  Gut       Date:  2016-02-17       Impact factor: 23.059

8.  Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice.

Authors:  Takuya Kuno; Mio Hirayama-Kurogi; Shingo Ito; Sumio Ohtsuki
Journal:  Mol Pharm       Date:  2016-07-20       Impact factor: 4.939

9.  Gender-divergent profile of bile acid homeostasis during aging of mice.

Authors:  Zidong Donna Fu; Iván L Csanaky; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.

Authors:  Bret D Wallace; Adam B Roberts; Rebecca M Pollet; James D Ingle; Kristen A Biernat; Samuel J Pellock; Madhu Kumar Venkatesh; Leah Guthrie; Sara K O'Neal; Sara J Robinson; Makani Dollinger; Esteban Figueroa; Sarah R McShane; Rachel D Cohen; Jian Jin; Stephen V Frye; William C Zamboni; Charles Pepe-Ranney; Sridhar Mani; Libusha Kelly; Matthew R Redinbo
Journal:  Chem Biol       Date:  2015-09-10
View more
  18 in total

1.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 2.  Bioavailability Based on the Gut Microbiota: a New Perspective.

Authors:  Feng Zhang; Fang He; Li Li; Lichun Guo; Bin Zhang; Shuhuai Yu; Wei Zhao
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-29       Impact factor: 11.056

3.  Gut Microbiota Modulates Interactions Between Polychlorinated Biphenyls and Bile Acid Homeostasis.

Authors:  Sunny Lihua Cheng; Xueshu Li; Hans-Joachim Lehmler; Brian Phillips; Danny Shen; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2018-12-01       Impact factor: 4.849

4.  Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus.

Authors:  Kim B Pedersen; Casey F Pulliam; Aarshvi Patel; Fabio Del Piero; Tatiane T N Watanabe; Umesh D Wankhade; Kartik Shankar; Chindo Hicks; Martin J Ronis
Journal:  Carcinogenesis       Date:  2019-04-29       Impact factor: 4.944

5.  RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice.

Authors:  Zidong Donna Fu; Felcy P Selwyn; Julia Yue Cui; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2017-09-22       Impact factor: 3.922

6.  PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice.

Authors:  Cindy Yanfei Li; Joseph L Dempsey; Dongfang Wang; SooWan Lee; Kris M Weigel; Qiang Fei; Deepak Kumar Bhatt; Bhagwat Prasad; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2018-05-16       Impact factor: 3.922

7.  Gut Microbiome Critically Impacts PCB-induced Changes in Metabolic Fingerprints and the Hepatic Transcriptome in Mice.

Authors:  Joe Jongpyo Lim; Xueshu Li; Hans-Joachim Lehmler; Dongfang Wang; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

Review 8.  Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach.

Authors:  Emily J Cox; Dan-Dan Tian; John D Clarke; Allan E Rettie; Jashvant D Unadkat; Kenneth E Thummel; Jeannine S McCune; Mary F Paine
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  An 'Omics Approach to Unraveling the Paradoxical Effect of Diet on Perfluorooctanesulfonic Acid (PFOS) and Perfluorononanoic Acid (PFNA)-Induced Hepatic Steatosis.

Authors:  Marisa Pfohl; Emily Marques; Adam Auclair; Benjamin Barlock; Rohitash Jamwal; Michael Goedken; Fatemeh Akhlaghi; Angela L Slitt
Journal:  Toxicol Sci       Date:  2021-04-12       Impact factor: 4.849

10.  Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome.

Authors:  María Callejo; Gema Mondejar-Parreño; Bianca Barreira; José L Izquierdo-Garcia; Daniel Morales-Cano; Sergio Esquivel-Ruiz; Laura Moreno; Ángel Cogolludo; Juan Duarte; Francisco Perez-Vizcaino
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.